BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)
CUSIP: 09058V103
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 210,587,372
- Total 13F shares
- 69,068,637
- Share change
- +1,725,349
- Total reported value
- $384,022,057
- Put/Call ratio
- 31%
- Price per share
- $5.56
- Number of holders
- 112
- Value change
- +$3,627,924
- Number of buys
- 58
- Number of sells
- 44
Quarterly Holders Quick Answers
What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09058V103:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.6%
|
11,716,784
|
$98,421,000 | — | 31 Mar 2017 | |
| VHCP Management II, LLC |
13F
|
Company |
2.9%
|
6,071,142
|
$50,998,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
6,014,277
|
$50,520,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.4%
|
5,011,763
|
$42,098,000 | — | 31 Mar 2017 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.7%
|
3,489,795
|
$29,314,000 | — | 31 Mar 2017 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.6%
|
3,458,120
|
$29,048,000 | — | 31 Mar 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.5%
|
3,153,628
|
$26,491,000 | — | 31 Mar 2017 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.5%
|
3,085,236
|
$25,916,000 | — | 31 Mar 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
2,838,649
|
$23,845,000 | — | 31 Mar 2017 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
2,272,104
|
$19,083,000 | — | 31 Mar 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.88%
|
1,844,636
|
$15,495,000 | — | 31 Mar 2017 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.76%
|
1,603,001
|
$13,465,000 | — | 31 Mar 2017 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.71%
|
1,500,000
|
$12,600,000 | — | 31 Mar 2017 | |
| FMR LLC |
13F
|
Company |
0.69%
|
1,456,885
|
$12,238,000 | — | 31 Mar 2017 | |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ |
13F
|
Company |
0.51%
|
1,078,345
|
$9,058,000 | — | 31 Mar 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.45%
|
956,098
|
$8,031,000 | — | 31 Mar 2017 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.44%
|
920,310
|
$7,731,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.43%
|
908,763
|
$7,633,000 | — | 31 Mar 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.37%
|
787,689
|
$6,616,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
773,115
|
$6,493,000 | — | 31 Mar 2017 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.26%
|
541,128
|
$4,545,000 | — | 31 Mar 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.24%
|
500,000
|
$4,200,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.23%
|
474,185
|
$3,983,000 | — | 31 Mar 2017 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.22%
|
457,647
|
$3,844,000 | — | 31 Mar 2017 | |
| EMORY UNIVERSITY |
13F
|
Company |
0.18%
|
375,348
|
$3,153,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
361,288
|
$3,035,000 | — | 31 Mar 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.17%
|
352,100
|
$2,958,000 | — | 31 Mar 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
333,373
|
$2,801,000 | — | 31 Mar 2017 | |
| University Of Notre Dame du Lac |
13F
|
Individual |
0.15%
|
322,164
|
$2,706,000 | — | 31 Mar 2017 | |
| ISZO CAPITAL MANAGEMENT LP |
13F
|
Company |
0.15%
|
307,366
|
$2,582,000 | — | 31 Mar 2017 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.12%
|
252,060
|
$2,117,000 | — | 31 Mar 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.12%
|
250,855
|
$2,107,000 | — | 31 Mar 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.11%
|
223,678
|
$1,878,000 | — | 31 Mar 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
219,203
|
$1,841,000 | — | 31 Mar 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.1%
|
202,317
|
$1,700,000 | — | 31 Mar 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.07%
|
157,383
|
$1,322,000 | — | 31 Mar 2017 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.07%
|
144,000
|
$1,210,000 | — | 31 Mar 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
134,525
|
$1,130,000 | — | 31 Mar 2017 | |
| PDT Partners, LLC |
13F
|
Company |
0.06%
|
129,200
|
$1,085,000 | — | 31 Mar 2017 | |
| Gotham Asset Management, LLC |
13F
|
Company |
0.06%
|
126,553
|
$1,063,000 | — | 31 Mar 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.06%
|
125,947
|
$1,058,000 | — | 31 Mar 2017 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.06%
|
119,978
|
$1,008,000 | — | 31 Mar 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.06%
|
118,300
|
$994,000 | — | 31 Mar 2017 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
114,300
|
$960,000 | — | 31 Mar 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.05%
|
110,805
|
$931,000 | — | 31 Mar 2017 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.05%
|
109,625
|
$921,000 | — | 31 Mar 2017 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
107,620
|
$904,000 | — | 31 Mar 2017 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.05%
|
95,908
|
$806,000 | — | 31 Mar 2017 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
87,468
|
$735,000 | — | 31 Mar 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
80,103
|
$673,000 | — | 31 Mar 2017 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q2 2017
As of 30 Jun 2017,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,068,637 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, DEERFIELD MANAGEMENT CO, MILLENNIUM MANAGEMENT LLC, RTW INVESTMENTS, LP, FMR LLC, and VHCP Management II, LLC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
114
Q2 2017 holders
112
Holder diff
-2
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.